STROMAL SPINDLE CELLS CONTAIN AROMATASE IN HUMAN BREAST-TUMORS

被引:144
作者
SANTEN, RJ
MARTEL, J
HOAGLAND, M
NAFTOLIN, F
ROA, L
HARADA, N
HAFER, L
ZAINO, R
SANTNER, SJ
机构
[1] WAYNE STATE UNIV, HARPER HOSP, SCH MED, DEPT INTERNAL MED, DETROIT, MI 48201 USA
[2] PENN STATE UNIV, MILTON S HERSHEY MED CTR, CTR BIOSTAT & EPIDEMIOL, HERSHEY, PA 17033 USA
[3] PENN STATE UNIV, MILTON S HERSHEY MED CTR, DEPT PATHOL, HERSHEY, PA 17033 USA
[4] YALE UNIV, SCH MED, DEPT OBSTET & GYNECOL, NEW HAVEN, CT 06510 USA
[5] FUJITA HLTH UNIV, SCH MED, INST COMPREHENS MED SCI, DIV MOLEC GENET, TOYOAKE, AICHI 47011, JAPAN
关键词
D O I
10.1210/jc.79.2.627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In situ synthesis of estrogens by breast cancer tissue provides a potential explanation for the high concentrations of estradiol in mammary neoplasms in postmenopausal women. A major metabolic pathway for estrogen biosynthesis is the conversion of androstenedione to estrone via the enzyme aromatase. Biochemical studies have demonstrated aromatase in tumor tissue, but at relatively low and not clearly biologically significant levels. The present study tested the hypothesis that tumor levels of aromatase, albeit low, could be biologically important if present in high concentrations in focal clusters of specific cell types. A pilot study used an immunohistochemical method in frozen sections of fresh breast tumors as an optimal means to detect aromatase. Twelve of 18 tumors contained aromatase-positive cells, some with highly intense staining. A follow-up study then attempted to precisely define the types of cells containing aromatase and correlate the immunohistochemical findings with biochemical aromatase activity. A modified H-score (histological scoring system) was used to semiquantitate the amount of aromatase staining in tumor epithelial, stromal spindle, stromal inflammatory, and normal breast epithelial cells. We found that immunohistochemical staining for aromatase predominated in stromal spindle cells with a median H-score of 13, whereas tumor epithelial, stromal inflammatory, and normal breast elements contained lesser amounts (median H-scores of 4.8, 0.03, and 0.5, respectively). The H-score for stromal spindle cells, but not those for other cell types, correlated highly with the biochemical aromatase assay (P < 0.01). Using a cut-off parameter estimated by a sensitivity/specificity (receiver operating curve) analysis, 62% of tumors were classified as aromatase positive based on stromal spindle cell staining. A similar number were also positive by biochemical assay, with concordance between the two methods of 77%. These observations provide substantial evidence for the presence of aromatase in human breast tumors, particularly in stromal spindle cells, and support the biological importance of aromatase for in situ production of estradiol.
引用
收藏
页码:627 / 632
页数:6
相关论文
共 27 条
[1]   AROMATIZATION OF ANDROGENS BY HUMAN BREAST-CANCER [J].
ABULHAJJ, YJ ;
IVERSON, R ;
KIANG, DT .
STEROIDS, 1979, 33 (02) :205-222
[2]  
Agresti A., 1990, CATEGORICAL DATA ANA
[3]  
BAILAR JC, 1981, MED USES STATISTICS
[4]   DISTRIBUTION OF AROMATASE-IMMUNOREACTIVE CELLS IN THE MOUSE FOREBRAIN [J].
BALTHAZART, J ;
FOIDART, A ;
SURLEMONT, C ;
HARADA, N .
CELL AND TISSUE RESEARCH, 1991, 263 (01) :71-79
[5]   IMMUNOCYTOCHEMICAL LOCALIZATION OF AROMATASE IN THE BRAIN [J].
BALTHAZART, J ;
FOIDART, A ;
HARADA, N .
BRAIN RESEARCH, 1990, 514 (02) :327-333
[6]   DISTRIBUTION OF AROMATASE IN THE BRAIN OF THE JAPANESE-QUAIL, RING DOVE, AND ZEBRA FINCH - AN IMMUNOCYTOCHEMICAL STUDY [J].
BALTHAZART, J ;
FOIDART, A ;
SURLEMONT, C ;
VOCKEL, A ;
HARADA, N .
JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 301 (02) :276-288
[7]   CORRELATION OF BREAST-TUMOR AROMATASE-ACTIVITY AND RESPONSE TO AROMATASE INHIBITION WITH AMINOGLUTETHIMIDE [J].
BEZWODA, WR ;
MANSOOR, N ;
DANSEY, R .
ONCOLOGY, 1987, 44 (06) :345-349
[8]   AROMATASE-ACTIVITY AND ESTRADIOL IN HUMAN BREAST-CANCER - ITS RELATIONSHIP TO ESTRADIOL AND EPIDERMAL GROWTH-FACTOR RECEPTORS AND TO TUMOR-NODE-METASTASIS STAGING [J].
BOLUFER, P ;
RICART, E ;
LLUCH, A ;
VAZQUEZ, C ;
RODRIGUEZ, A ;
RUIZ, A ;
LLOPIS, F ;
GARCIACONDE, J ;
ROMERO, R .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :438-446
[9]  
BRADLOW HL, 1982, CANCER RES, V42, P3382
[10]  
BULIN SE, 1993, J CLIN ENDOCR METAB, V77, P1622